Overall, this part of the results reveals the different roles of prostate cancer epithelial cells with high and low TDP2 expression in tumor occurrence and development, especially their differences in immunosuppression, epithelial-mesenchymal transition (EMT), and myeloid immune response. The gene discussed is TDP2; the disease is prostate carcinoma.